UTHR Exercise Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Jul 20, 2026
Exercise
Calculated transaction value
$0
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Jul 17, 2026
Public filing date
Jul 20, 2026
Filing lag
Filed 3 days later
UTHR daily price context
Close on/before transaction
$535.67
Jul 17, 2026
Close before public filing
$535.67
Jul 17, 2026
Return since public filing
-8.48%
Through Sep 3, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option on Common Stock
- Quantity / price
- 9,500 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001106578-26-000101
Filing cohort
Transactions in this filing
Showing 13 of 13
Trades
13
Issuers
1
Estimated value
$6.39M
Buys / sales
0 / 11
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Jul 17, 2026 | $384.89K |
| United Therapeutics Corp UTHR | Sale | Jul 17, 2026 | $1.13M |
| United Therapeutics Corp UTHR | Sale | Jul 17, 2026 | $623.44K |
| United Therapeutics Corp UTHR | Sale | Jul 17, 2026 | $443.03K |
| United Therapeutics Corp UTHR | Sale | Jul 17, 2026 | $135.71K |
| United Therapeutics Corp UTHR | Sale | Jul 17, 2026 | $158.93K |
| United Therapeutics Corp UTHR | Exercise | Jul 17, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Jul 17, 2026 | $127.4K |
| United Therapeutics Corp UTHR | Sale | Jul 17, 2026 | $1.26M |
| United Therapeutics Corp UTHR Current | Exercise | Jul 17, 2026 | $0 |
| United Therapeutics Corp UTHR | Sale | Jul 17, 2026 | $126.94K |
| United Therapeutics Corp UTHR | Sale | Jul 17, 2026 | $227.87K |
| United Therapeutics Corp UTHR | Sale | Jul 17, 2026 | $483.52K |